ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 42 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $595 | -99.9% | 1,654,153 | +4.1% | 0.00% | -100.0% |
| Q3 2022 | $953,000 | +18.5% | 1,589,369 | -1.5% | 0.00% | – |
| Q2 2022 | $804,000 | -42.1% | 1,613,113 | +2.8% | 0.00% | -100.0% |
| Q1 2022 | $1,389,000 | -23.4% | 1,569,164 | -3.1% | 0.00% | 0.0% |
| Q4 2021 | $1,813,000 | -30.6% | 1,619,125 | +10.3% | 0.00% | -50.0% |
| Q3 2021 | $2,613,000 | -41.3% | 1,468,207 | +8.8% | 0.00% | -33.3% |
| Q2 2021 | $4,453,000 | +6.7% | 1,349,288 | +8.3% | 0.00% | 0.0% |
| Q1 2021 | $4,175,000 | +11183.8% | 1,246,275 | +6426.4% | 0.00% | – |
| Q2 2020 | $37,000 | +5.7% | 19,096 | +66.0% | 0.00% | – |
| Q2 2019 | $35,000 | -43.5% | 11,503 | -23.4% | 0.00% | – |
| Q1 2019 | $62,000 | -13.9% | 15,012 | -17.3% | 0.00% | – |
| Q4 2018 | $72,000 | -72.1% | 18,149 | -46.0% | 0.00% | – |
| Q3 2018 | $258,000 | -27.9% | 33,582 | -17.4% | 0.00% | – |
| Q2 2018 | $358,000 | – | 40,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |